When you think of osteoarthrosclerosis, it’s usually the most severe form of the disease, caused by calcification of the spine.

But a new treatment called osteoarthropathy treatment is also gaining popularity.

In a study published last week in the journal Annals of Internal Medicine, researchers at Harvard Medical School and the Mayo Clinic found that patients who received the treatment were twice as likely to have pain-free living as those who didn’t.

The treatment, called a cortisone injection, is being used to treat lupiforms and to treat certain forms of osteomyelitis, a condition where the joints are not properly supported.

“It’s a wonderful drug to have, because it’s not going to kill you, it doesn’t have any side effects, it is inexpensive, and it’s safe,” said Dr. Robert R. Hargrave, who co-led the study with Dr. Stephen L. Sondak, a professor of medicine at the Mayo clinic.

“I think the benefit of it is the very low risk, because the drug has no side effects.”

The research team, which included Dr. Sajid Hasan and Dr. Peter D. Smith, also noted that while the treatment is effective for osteoarsis, it may not be the treatment for every form of osteopathy, such as osteoporosis.

In that regard, the researchers note that it is not known how many people actually respond to the treatment.

“We are working on a drug that would be suitable for people with osteoathritis,” said Hasan.

“The goal is to treat all types of osteopathies.”

The researchers also recommend that people with moderate to severe osteoarchitectonic disease receive an injection of cortisones or steroids at least three times a week.